Royan Cord Blood and Stem Cell Technology Company enjoys a Research and Development Department (R&D) through which we make a research and clinical study on a wide variety of diseases could be cured with stem cells. No wonder, as we go ahead with new findings and potentials regarding cord blood stem cells, R&D department finds itself in arena of making crucial efforts on the path toward organizational development and enrichment.
In the meantime, thanks to our scientific staff and researchers, we have taken fruitful measures in research activities including:
-
Releasing and publicizing articles and magazines
-
Taking part in various national, regional and international congresses, conferences and exhibitions
-
Representing two articles in the 28th Immunogenic Congress held in Stockholm
-
Representing one article about evaluation of blood factors of the cord blood samples stored in cord blood bank and its relationship with CD34 in the 11th Symposium on cord blood bank held in San Francisco
-
Registering a patent on isolating the stem cells of mesenchyme in Wharton Jelly, taking advantage of PBS which is so fast and economic
And some more, to name but a few. The data represented here are so concise and in brief, not to taking a long time or get you bored. We invite our counterparts from various related scientific communities and centers from far beyond borders to share their experiences, knowledge and experiences with us so that we all can play our roles much more constructive than before and pay the debt we owe to the human communities toward enjoying a healthy life.